Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03136705 · ClinicalTrials.gov registry record · Phase 1
Healthy Combine Study
A Phase 1 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT03136705 is a Phase 1 study that has completed, run by Northwestern University. The registered enrollment target is 39 participants.
The verdict
NCT03136705, a Phase 1 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
STUDY SUMMARY Title: EFFECTS OF NICOTINAMIDE AND LANTHANUM CARBONATE ON PHOSPHORUS HOMEOSTASIS Protocol Number:STU00090161 Phase: Phase 1, detailed physiologic study Methodology: double blind, randomized, placebo-controlled, 2x2 factorial Study Duration: 12-18 months (to complete the entire study protocol) Study Center: Single-center Objectives: Define short-term effects of the interventions (lanthanum carbonate and nicotinamide) on indices of phosphate handling Number of Subjects: 80 Diagnosis and Main Inclusion Criteria: Healthy volunteers Study Product(s), Dose,Route, Regimen: Nicotinamide, 750 mg by mouth twice daily, Lanthanum carbonate, Fosrenol, 1000 mg by mouth three times daily with meals Duration of administration: 2 weeks (length of time study participants are enrolled in study) Reference therapy: reference is a placebo Statistical Methodology: Repeated measures analysis using mixed linear models
Interventions
- DRUG Nicotinamide
- DRUG Lanthanum Carbonate
- DRUG Lanthanum Carbonate Placebo
- DRUG Nicotinamide Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2016-02-03 |
| Est. Completion | 2017-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03136705
The ClinicalTrials.gov registry entry for NCT03136705 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Nicotinamide is the first listed.
NCT03136705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03136705 about?
NCT03136705 is a clinical study titled "Healthy Combine Study". STUDY SUMMARY Title: EFFECTS OF NICOTINAMIDE AND LANTHANUM CARBONATE ON PHOSPHORUS HOMEOSTASIS Protocol Number:STU00090161 Phase: Phase 1, detailed physiologic study Methodology: double blind, randomized, placebo-controlled, 2x2 factorial Study Duration: 12-18 months (to complete the entire study pr...
What is the current status of trial NCT03136705?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2016-02-03. Estimated completion is 2017-12-01.
What interventions are being tested in trial NCT03136705?
The interventions under investigation include: Nicotinamide (DRUG), Lanthanum Carbonate (DRUG), Lanthanum Carbonate Placebo (DRUG), Nicotinamide Placebo (DRUG).
Who is sponsoring clinical trial NCT03136705?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.